Skip to main content
Caplight Logo









Negus Med

Negus Med

Private
NairobiHealthcare & Life Scienceshttps://negusmed.com/

Last Round

Seed

Mar 1, 2023

Total Funding Raised

$150,000

Company Overview

Negus Med is a medical equipment company that develops digital healthcare solutions, including a platform for sharing mobile medical devices, pay-per-use financing, and asset tracking.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Lending & Credit, Vertical SaaS

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Marketplace Commission, Services & Consulting

AI Layer

Application

Keywords

medical equipment marketplaceequipment-as-a-servicemedical device financingpay-per-use modelequipment sharingmedical equipment distributionhealthcare equipment leasingIoT asset trackingusage-based billingadvanced wound caresurgical equipmentmedtechhealthtechTherapy as a Servicemedical device manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Negus Med Comparables

Compare Negus Med with similar companies based on industry and business-model similarity.

Negus Med comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Viebeg Technologies
82%
African Asset Finance Company
78%
MediQuip Global Limited
73%

Negus Med Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2023
GrantSep 27, 2022
AcceleratorDec 2, 2021

Key People

Founding team and executive leadership

Austin Omune

Chief Executive Officer

Executive Team

David Onyango

Chief Executive Officer

Executive Team

Negus Med Investors

Notable investors and investment history

Negus Med investors
InvestorRounds
HealthTech Hub AfricaAccelerator
Villgro AfricaSeed
Investing in Innovation (i3) AfricaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 48% MoM.

  • Mar 1, 2023

    $100K round from Villgro Africa

Negus Med Filings

Explore SEC and related filing metadata, where available.

Negus Med filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Negus Med's valuation, stock price, and market status.

Is Negus Med a public or private company?

Negus Med is a private company.

What is the current stock price of Negus Med?

Negus Med is a private company with no public stock price. No recent secondary market data is available.

How much is Negus Med worth (valuation)?

Valuation information for Negus Med is not publicly available.

Can I buy Negus Med stock?

Negus Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Negus Med's last funding round?

Funding round information for Negus Med is not publicly available.

Who are the main investors in Negus Med?

Investor information for Negus Med is not publicly disclosed.

Will Negus Med IPO soon?

No public IPO plans have been announced for Negus Med.

How can I track Negus Med secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Negus Med's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNairobi
Employee Range9
Year Founded2017
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?